Oncolytics Biotech (ONC) Insider Trading & Ownership C$1.42 +0.03 (+2.16%) As of 08/22/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Oncolytics Biotech (TSE:ONC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.82%Number OfInsiders Buying(Last 12 Months)5Amount OfInsider Buying(Last 12 Months)C$178.19KNumber OfInsiders Selling(Last 12 Months)0 Get ONC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ONC Insider Buying and Selling by Quarter Oncolytics Biotech Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/17/2025Allison HagermanSenior OfficerBuy4,600C$1.71C$7,866.007/17/2025Thomas HeinemanSenior OfficerBuy15,000C$1.74C$26,098.507/16/2025Jared Ryan KellySenior OfficerBuy50,400C$1.63C$82,284.507/15/2025Andrew P. AromandoSenior OfficerBuy25,500C$1.62C$41,425.927/15/2025Kirk LookSenior OfficerBuy12,800C$1.60C$20,517.12 (Data available from 1/1/2013 forward) ONC Insider Trading Activity - Frequently Asked Questions Who is on Oncolytics Biotech's Insider Roster? The list of insiders at Oncolytics Biotech includes Allison Hagerman, Andrew P. Aromando, Jared Ryan Kelly, Kirk Look, and Thomas Heineman. Learn more on insiders at ONC. What percentage of Oncolytics Biotech stock is owned by insiders? 3.82% of Oncolytics Biotech stock is owned by insiders. Learn more on ONC's insider holdings. Which Oncolytics Biotech insiders have been buying company stock? The following insiders have purchased ONC shares in the last 24 months: Allison Hagerman (C$7,866.00), Andrew P. Aromando (C$41,425.92), Jared Ryan Kelly (C$82,284.50), Kirk Look (C$20,517.12), and Thomas Heineman (C$26,098.50). How much insider buying is happening at Oncolytics Biotech? Insiders have purchased a total of 108,300 ONC shares in the last 24 months for a total of C$178,192.04 bought. Oncolytics Biotech Key ExecutivesDr. Matthew C. Coffey M.B.A.Ph.D., President, CEO & DirectorMr. Kirk J. Look C.A.CA, Chief Financial OfficerDr. Thomas C. Heineman M.D.Ph.D., Chief Medical OfficerMs. Allison Hagerman P.Eng.P.M.P., Vice President of Product Development1 recent tradesMs. Amy Goodowitz Levin B.S.N.R.N., Vice President of Clinical OperationsJon PattonDirector of Investor Relations & CommunicationMr. John Mark Lievonen BBAC.M., FCA, LLD, MBA, Consultant More Insider Trading Tools from MarketBeat Related Companies Fennec Pharmaceuticals Insider Trades Theratechnologies Insider Trades Medicenna Therapeutics Insider Trades Sernova Insider Trades Microbix Biosystems Insider Trades Hemostemix Insider Trades Innovotech Insider Trades Quest PharmaTech Insider Trades Kane Biotech Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying This page (TSE:ONC) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access